In 2001, the LRI awarded 12 novel research grants to investigators across the country to tackle different aspects of lupus in completely new and innovative ways. Click on the link to learn more about the rationale behind each project, the research plan, and what the findings will mean for the estimated 1-1.5 million Americans who suffer from lupus.

Novel Research Program Grant Recipients:


• Silvia Bolland, PhD, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD
  FcgRIIB: Susceptibility Factor in the Development of Lupus and Potential Target for New Therapies
• Philip L. Cohen MD, University of Pennsylvania School of Medicine, Philadelphia, PA
  C-mer Deficiency - A New Model of Systemic Lupus Erythematosus (S.L.E.)
• Mary K. Crow, MD, Hospital for Special Surgery, New York City, NY
  Mechanism of Immune System Activation in S.L.E.
• Betty Diamond, MD, Albert Einstein College of Medicine, Bronx, New York, NY
  A Model for Central Nervous System Disease in S.L.E.
• Edmund J. Gosselin, PhD, Albany Medical College, Albany, NY
  Inhibition and Elimination of Antigen-Specific Human B Cells Using a Novel Molecular Approach for Autoimmune Intervention
• Chandra Mohan, MD, PhD, University of Texas Southwestern Medical Center, Dallas, TX
  Novel Approaches to Studying End-Organ Susceptibility in Lupus
• Chaim Putterman, MD, Albert Einstein College of Medicine, Bronx, New York, NY
  The Human Renal Target for Anti-DNA Antibodies
• Stephen J. Rozzo, PhD, University of Colorado Health Sciences Center, Denver, CO
  Interferon-Inducible Ifi200 Genes: A New Potential Target in S.L.E.
• Barbara J. Vilen, PhD, University of North Carolina at Chapel Hill, NC
  Molecular Mechanisms of Overcoming Tolerance in Systemic Lupus Erythematosus
• Edward K. Wakeland, PhD, University of Texas Southwestern Medical Center, Dallas, TX
  Evaluation of Therapeutic Targets for Systemic Autoimmunity
• Martin Weigert, PhD, Princeton University, Princeton, NJ
  The Regulation and Loss of Regulation of Anti-DNA B cells
• Victoria P. Werth, MD, University of Pennsylvania School of Medicine, Philadelphia, PA
  Role of TNFa Polymorphism in Photosensitive Lupus Erythematosus